COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. New Mexico patients with a documented clinical need may be eligible for compounded tirzepatide.
New Mexico’s rural communities and tribal lands face significant healthcare access challenges. Compounding Finder helps New Mexico residents connect with licensed pharmacies that ship statewide.
Yes. The New Mexico Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.